# A Clinical Study for Inactivated Vaccine Against EV71

> **NCT02200237** · PHASE2 · COMPLETED · sponsor: **Medigen Vaccine Biologics Corp.** · enrollment: 366 (actual)

## Conditions studied

- Enterovirus 71 Human

## Interventions

- **BIOLOGICAL:** EV71 with adjuvant aluminium phosphate
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02200237
- **Lead sponsor:** Medigen Vaccine Biologics Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-05
- **Final completion:** 2017-08
- **Target enrollment:** 366 (ACTUAL)
- **Last updated:** 2017-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02200237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02200237, "A Clinical Study for Inactivated Vaccine Against EV71". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02200237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*